Ivan Spasojevic

11PUBLICATIONS
71CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMedical parasitologyBiomolecular modelling and designNanotoxicology, health and safety
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jun 29, 2026
BMX-001 acts as a selective chemoradioprotector in rectal cancer.

|Sep 03, 2025
Suppression of Paclitaxel-Induced Neuropathy and Ovarian Tumor Growth by Mn Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup> (BMX-001).

Ivan Spasojevic, Zhiqing Huang, Welida Tamires Alves da Silva

|Apr 26, 2025
Treatment with Manganese Porphyrin, MnTnBuOE-2-PyP<sup>5+</sup>, Suppressed the Activation of Macrophages in a Mouse Intracerebral Hemorrhage.

Shasha Zhang, Jie Cao, Ivan Spasojevic

|Apr 02, 2025
Effective extracellular payload release and immunomodulatory interactions govern the therapeutic effect of trastuzumab deruxtecan (T-DXd).

Li-Chung Tsao, John S Wang, Xingru Ma

|Dec 31, 2024
Design of an equilibrative nucleoside transporter subtype 1 inhibitor for pain relief.

Nicholas J Wright, Yutaka Matsuoka, Hyeri Park

|Nov 08, 2024
Safety Evaluations of Rapamycin Perfluorocarbon Nanoparticles in Ovarian Tumor-Bearing Mice.

Qingyu Zhou, John C Harding, Ping Fan

Pageof 2

Frequent Collaborators

3 joint publications

Ines Batinic-Haberle

3 joint publications

Artak Tovmasyan

3 joint publications

Huaxin Sheng

2 joint publications

Weina Duan